Waters Corporation ( WAT) - Key Metrics
WAT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $16.75 | -$1.38 | $2.04 | $1.54 |
| 2026Q1 | $15.43 | -$0.88 | -$0.04 | -$0.51 |
| 2025Q4 | $15.66 | $3.78 | $2.76 | $2.11 |
| 2025Q3 | $13.44 | $2.50 | $3.15 | $2.72 |
| 2025Q2 | $12.96 | $2.47 | $0.69 | $0.31 |
WAT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -68.22 |
| 2026Q1 | 0% | -87.43 |
| 2025Q4 | 0% | 25.12 |
| 2025Q3 | 0% | 29.17 |
| 2025Q2 | 0% | 35.67 |
WAT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.41% | 0% |
| 2026Q1 | -0.17% | 0% |
| 2025Q4 | 0.56% | 0% |
| 2025Q3 | 0.93% | 0% |
| 2025Q2 | 0.09% | 0% |
WAT
Price: $409.38
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.96 USD
P/E Ratio: 102.74
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 305400
Ebitda: 257.9 millionMarket Capitalization: 30.8 billion